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I. Introduction 
Chlorhexidine(CHX) is a cationic molecule 
belonging to the polybiguanide group of 
compounds. The bactericidal effect of the drug 
is the result of the cationic molecule altering 
the osmotic equilibrium of the microbes1). 
Generally, a 0.12% CHX mouth rinse is used to 
prevent dental plaque formation on the teeth 
and other plastic films2). Its use has been con-
stantly advocated after GTR surgery to prevent 
or at least to reduce membrane exposure and 
the incidence of wound infections1,3,4). In order 
to prevent membrane contamination, systemic 
antibiotics and local antimicrobial therapy with 
(0.12% or 0.2%) CHX solutions have been sug-
gested5). Alleyn et al.6) demonstrated greater 
bone regeneration in the bifurcation defects in 
dogs when topical CHX was used 
postoperatively. In addition, many studies have 
shown that periodontal ligament cells produce 
mineralized nodules in vitro7-9).1)
However, several studies have demonstrated 
the toxic effects of CHX on human cells and 
granulation tissue10). A review of the literature 
showed CHX to be harmful to a variety of 
mammalian cells, including sperm, poly-
morphonuclear leukocytes, macrophages, skin 
epithelial cells, erythrocytes, gingival fibro-
blasts and PDL cells11-18). In addition, some 
studies have reported that CHX application di-
rectly to surgical wounds in the oral cavity can 
delay and alter wound healing19-20).
Although there are no reports showing that 
immediate CHX mouth rinsing after GTR can 
approach PDL cells, it is difficult to state that 
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they cannot. Moreover, exposure of the GTR 
membrane during the healing period is common 
occurrence21-22), and when the membrane is ex-
posed, a 0.12% CHX gel and forceful irrigation 
with CHX using irrigating syringes is the rec-
ommended method for clinics23). The use of CHX 
in membrane exposure might increase the pos-
sibility of contact with the PDL cells.
The concentration range of the antiseptic 
that causes minimal tissue damage and is still 
an effective antimicrobial agent has not been 
established. In addition, the molecular mecha-
nisms underlying the cytotoxicity of CHX and 
the impairment of the function of human PDL 
fibroblasts are not clearly understood. 
The aim of this study was to determine the 
optimal concentration to obtain dual effects; 
not harmful to human PDL cells and have a 
bactericidal effect on periodontal pathogens. 
II. Material and Methods 
1) PDL cell culture 
Human PDL cells were cultured by using an 
explant technique that is described else-
where7,18). The human PDL cells were cultured 
from the middle third of the roots of premolars 
extracted for orthodontic reasons. The frag-
ments were grown in DMEM supplemented with 
10% fetal bovine serum (FBS) and antibiotics. 
The cultures were maintained at 37℃ in a hu-
midified atmosphere of 5% CO2 and 95% air. 
Experiments with PDL cells were performed by 
using the cells between the third and four 
passage. 
2) Cell viability (MTT) assay 
The cell viability was determined by examin-
ing the of the cells to metabolically reduce the 
tetrazolium salt, 3-〔4,5-dimethylthiazol-2-y
l〕-2,5-diphenyl tetrazolium bromide(MTT), to 
a purple formazan dye, using a kit purchased 
from Boehringer Mannheim Corp. (Indianapolis, 
IN, USA). Individual wells of the 96-well mi-
crotiter tissue culture plates were seeded with 
3x104 cells in 0.2 ml of the growth medium and 
incubated overnight at 37℃. The growth me-
dium was then removed and replaced with 
DMEM supplemented with 10% fetal bovine se-
rum (FBS) and antibiotics, with  various CHX 
concentrations (0(control), 0.12, 0.012, 0.0012, 
0.00012%). The CHX(Sigma, 2.0%) was diluted 
with the media(DMEM +10%FBS+ 1x anti-
biotics). After 30, 60, 120 seconds of exposure, 
MTT was added to a final concentration of 0.5 
mg/ml and the cells incubated for 4h at 37℃. 
Using the solubilization solution provided in 
the kit, the purple formazan crystals, which 
were produced in the kit, and the purple for-
mazan crystals, which were produced as a result 
of the reduction of MTT by the metabolically 
active cells, were dissolved overnight exposure 
at 37℃. The absorbance was read at 490nm us-
ing a microtiter plate spectrophotometer.  
3) Mineralized nodule formation 
The PDL cells were seeded at an initial den-
sity of 5x104 cells in 12-well microtiter tissue 
culture plates using DMEM with 10% FBS. 
Before reaching confluence, the growth medium 
was then removed and replaced with DMEM 
with various CHX concentration (0 (control me-
dium), 0.12, 0.012, 0.0012, 0.00012%). After 30, 
60 and 120 seconds, the test medium was re-
moved, and the PDL cells were washed 2x with 
the HBSS solution. The PDL cells were cultured 
377
time
Number of cell (mean±SD)
control 0.12% 0.012% 0.0012% 0.00012%
30 sec 0.143±0.014 0.028±0.015* 0.144±0.005 0.222±0.047 0.185±0.034
60 sec 0.156±0.023 0.028±0.007* 0.139±0.040 0.181±0.022 0.157±0.010
120 sec 0.164±0.054 0.010±0.004* 0.184±0.012 0.207±0.060 0.160±0.019
* significant difference(p<0.05) between control and test group by Kruskal-Wallis Test, SD: standard deviation 
Table 1. Cell cytotoxicity according to the concentration of CHX and time course 
time
Number of bone nodule (mean±SD)
control 0.12% 0.012% 0.0012% 0.00012%
30 sec 10±1 0* 2±0* 5.667±0.577* 6.667±0.577*
60 sec 9.333±0.577 0* 1±0* 3.333±0.577* 3.333±0.577*
120 sec 11.667±2.081 0* 0.667±0.577* 2.333±0.577* 3.333±0.577*
* significant difference(p<0.05) between control and test group by Kruskal-Wallis Test, SD: standard deviation
Table 2. The formation of bone nodule according to the concentration of CHX and time course 
for 21 days in DMEM containing 10% FBS, min-
eralization supplements, 50μg/ml ascorbic acid, 
10mM β-glycerophosphate and 100nM 
dexamethasone. The medium for all groups was 
changed every 2 days. In order to detect the 
formation of mineral-like nodules, the cells 
were washed three times with saline and fixed 
with dehydrated ethanol for 20 min. The cell 
layers were then stained with 1% alizarin red S 
in 0.1% NA4OH for 5 min. The alizarin 
red-positive nodules on the criss crossing cell 
layers were defined as mineralized nodules, and 
the numbers of nodules per well was counted 
using an optical microscope. 
4) MIC 
Seven consecutive distinct clinical isolates of 
Fusobacterium nucleatum 25586, Porphyromonas 
nigrescens 33563, Porphyromonas gingivalis 
w50, Porphyromonas endodontalis 35406 and 
Prevotella intermedia 25611 from the Biochemisty 
Laboratory were investigated. The bacteria were 
identified according to standard microbiological 
procedures. 
The MIC of CHX was determined using the 
method reported by Murray. The MIC was in-
terpreted according to the National Committee 
for Clinical Laboratory Standards. Briefly, a 
concentration of approximately 5x105 of the 
bacterial cultures was inoculated into 10-1000 
serial dilutions (0.12-0.00012%) of CHX in a 
Mueller-Hinton broth for MIC detection. 
5) Statistical analyses 
The statistical analyses were performed using 
the Kruskal-Wallis Test. All experiments were 
performed at least three times. The graphical 
data is presented as the arithmetic mean per-
centages of the control ± standard deviation. 
The differences between the control and ex-
perimental values were analyzed and a P-value 
≤0.05 was considered significant. 
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III. Results 
PDL cell viability is shown in table 1. The 
cell viability was affected by exposure to only 
0.12% CHX exposure. At concentrations ≤ 
0.012% CHX, the cell viability was not sig-
nificant different than the control. Time was 
found to be an independent factor for cell 
viability. 
Numerous mineralized nodules were identified 
as darkly stained patches in the control group, 
whereas an extremely small number of miner-
alized nodules were observed in the  CHX group 
(Table 2). 
The PDL cells cultured in the absence of CHX 
differentiated in four stages; confluent, multi-
layer, nodule and mineralization. Therefore, 
many mineralized nodules were produced. 
(Figure 1) 
Figure 1. Numerous mineralized nodules were
identified as dartly stained patches in the 
control group (PDL cells cultured in the 
absence of CHX). (Alizarin red stain, 
magnification ×100).
The cells treated with 0.12% did not form a 
confluent monolayer and failed to form miner-
alized nodules.(Figure 2) 
Figure 2.  Scattered PDL fibroblasts did not 
form the mineralized nodules in the group 
treated with 0.12%-30 seconds CHX. 
(Alizarin red stain, magnification ×100).
However, a small number of mineralized 
nodules were present in the 0.012-0.00012% 
CHX groups. PDL cells in certain areas also 
proliferated and formed multilayers of fibro-
blastic cells but they remained the same there-
after without further differentiation into the 
nodules and mineralization stages.(Figure 3) 
Figure 3. PDL cells in certain areas prolif-
erated and formed multilayers of fibro-
blastic cells but remained the same 
thereafter without further cell differ-
entiation into the mineralized nodules in 
the group treated with 0.012%-30 sec-
onds CHX. (Alizarin red stain, magnifica-
tion ×100).
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The PDL cells in some parts proliferated and 
differentiated into mineralized nodules.(Figure 4,5) 
Figure 4. PDL cells in certain areas prolif-
erated and differentiated into the mineral-
ized nodules in the group treated with 
0.0012%-30 seconds CHX. (Alizarin red 
stain, magnification ×100).
Figure  5. PDL cells in more larger areas than 
0.0012% group proliferated and differentiated
into the mineralized nodules in the group 
treated with 0.00012%-30 seconds CHX. 
(Alizarin red stain, magnification ×100).
The MIC of CHX for the Fusobacterium nucle-
atum 25586, Porphyromonas nigrescens 33563, 
Porphyromonas gingivalis w50, Porphyromonas 
endodontalis 35406, Prevotella intermedia 25611 
was found to be 0.0012% 
IV. Discussion 
A CHX mouth rinse is a widely used adjunct 
to in periodontal therapy owing to its bacter-
icidal effect4). There are numerous reports on 
its safety as an oral rinse, but its reported ef-
fects on wound healing have been 
contradictory. Several reports on gingival 
wound healing concluded that the drug did not 
interfere with healing24-26). However, many 
studies reported a significant delay in palate 
mucosa-osseous wound healing after applying 
0.5% CHX application20). If CHX can come into 
contact with the periodontal ligament cells 
during the initial stages of healing, it is possi-
ble that the drug may adversely affect the re-
generation of the attachment apparatus. This of 
course would be particularly true for GTR. To 
date, there is a dearth of information definin-
ing the lethal CHX dose, and perhaps more im-
portantly, the effects of non-lethal doses on 
the secretory phenotype (bone nodule for-
mation) of human PDL cells has not been 
investigated. 
This study found there to be some CHX pro-
tective mechanism in the organism, because 
CHX concentrations, which are highly cytotoxic 
in vitro generally, do not harm cells in vivo. 
The epithelial barrier function can protect the 
underlying cells27). It has been shown that the 
serum protects cells from the cytotoxic effects 
of CHX12). It has also been suggested that 
there is a threshold value of tissue injury in 
the wound that must be exceeded before the 
repair process is impaired28). Studies have 
found that  in gingivectomies, the surface of 
the wound becomes covered with a fibrin clot, 
in which the PMNs become incorporated form-
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ing a  polyband  layer. Epithelial cells mi-
grate to cover the wound under this layer. The 
"polyband" layer may offer a protective surface 
that prevents CHX from reaching the  con-
nective tissues25). In order to reflect these CHX 
protective mechanisms in organisms, the cells 
were exposed to low concentrations 
(0.12-0.00012%) and for a short time (30-120 
seconds). The results showed that the MIC of 
CHX on periodontal pathogens is 0.0012%. That 
is a 100 dilution of the clinically used concen-
tration (0.12%). 
In the cell viability test, only 0.12% CHX af-
fected cell proliferation. In many other studies, 
the cytotoxic concentration of CHX on fibro-
blasts was lower than but the exposure time 
was more than 360 times that in this study. 
Another reason for our result being higher than 
that reported elsewhere may be the difference 
in the composition of the media used. The me-
dia used as diluent of CHX (Sigma, 2.0%) in 
this study was DMEM +10%FBS+ 1x antibiotics. 
Hidalgo et al.29) reported that 10% FBS added to 
the culture media appeared to have an attenu-
ating effect against CHX-induced cytotoxicity, 
which resulted in a higher cell survival rate, a 
higher ATP intracellular level and a higher rate 
of DNA synthesis.  
Recently CHX was found to impair the cell 
function of the target cells at concentrations 
that had no effect on cellular viability. Many 
reports strongly suggest that CHX can inhibit 
the formation of mineralized bone nodules via  
different mechanisms, possibly inhibiting pro-
tein synthesis, in particular collagen, DNA 
synthesis and the mitochondrial activity. In 
this study, all CHX groups showed a significant 
reduction in bone nodule formation by PDL 
cells. Perhaps the more interesting observation 
was the significant reduction at CHX concen-
trations that had no effect on cellular 
proliferation. The concentration of affecting the 
formation of bone nodules of the PDL cells 
(0.00012%) was lower than the cytotoxic con-
centration (0.12%), and the concentration for 
minimal inhibition on periodontal pathogens 
was 0.0012%. Therefore, if CHX comes into 
contact with the periodontal ligament cells 
during the initial stages of healing after a 
GTR, the drug might adversely affect the re-
generation of the attachment apparatus.
V. Conclusions
In conclusion, this study demonstrated in vi-
tro that CHX adversely affects the formation of 
bone nodules by human PDL fibroblasts. 
Therefore, it may be prudent to avoid contact 
with CHX until wound healing is well advanced. 
In order for CHX to be used as a antimicrobial 
agent in wound healing after periodontal sur-
gery further studies will be needed to de-
termine when the PDL cells are free from CHX.
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사람치주인대섬유모세포에 의한 골결절 형성시 
Chlorhexidine의 효과
최희준1, 지숙1, 국중기2,5, 장현선1,5, 박주철3,5, 김흥중4,5, 김종관6, 김병옥1,5,*
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사람치주인대섬유모세포(human periodontal ligament fibroblast, PDLF)의 기능 손상과 클로르헥시딘
(Chlorhexidine, CHX)의 세포독성에 관한 분자적인 기전은 최근까지도 불명확하다. 이 연구의 목적은 PDLF에 
의한 골결절 형성에 있어서 CHX의 효과를 평가하고, 치주수술후에 치주병원균의 최소억제농도(minimal in-
hibitory concentration, MIC)를 평가하고자 하였다. CHX의 세포독성을 평가하기 위하여 MTT assay법을 실
시하였다. CHX은 0.12 %에서 0.00012%까지, 즉 10-1000배로 희석시킨 후 30, 60, 120초 동안 PDLF에 적용
되었고, 석회화된 결절은 alizarin red 용액에 염색되었다. 치주병원균에 대한 CHX의 MIC가 평가되었다. 이 
연구 결과, 세포생존율 검사에서는, 단지 0.12 % CHX 에 노출되었던 세포들만 세포 증식 소견을 다소 나타내
었다. 모든 CHX 농도(0.12%-0.00012%)에서 PDLF에 의한 골결절 형성은 의미있는 감소를 나타내었다. 또한 
치주병원균에 대한 CHX의 MIC는 0.0012 %로 나타났다. PDLF의 골결절 형성에 영향을 주는 농도(0.00012%)
는 세포독성을 나타내는 농도(0.12%)보다 더 낮은 농도를 보였고, 치주병원균의 최소억제에 필요한 농도는 
0.0012%로 나타났다. 이러한 결과들은 통상적으로 상용되는CHX이 PDLF에 의한 골결절 형성에 있어서 영향을 
미칠 수 있음을 시사하였다.2)
주요어：클로르헥시딘, 사람치주인대섬유모세포, 골결절, 최소억제농도

